• Blood Centrifugation

    Sunstein prosecuted blood centrifugation patents for Haemonetics Corporation, a leader in the field of blood processing. The patented technologies allow blood components to be collected and processed for life-saving transfusions.

  • Purification

    Innovations by DEKA Research increase the efficiency of water purification systems, while reducing power and maintenance requirements. International patent applications like the one Sunstein prepared for DEKA can lead to worldwide adoption of a useful technology – one that can supply the developing world with access to safe water.

  • Shaft/hub

    Custom Machine & Tool Co. invented a novel shaft/hub connection device for precise component positioning and tight run-out control in demanding torque transmission applications such as timing-belt pulleys. Rigorous engineering analyses, as shown, demonstrate the benefits of CMT’s invention compared to other connection systems. The patent Sunstein obtained bolsters CMT’s position in a crowded marketplace.

  • Intravascular Stent

    Sunstein prosecuted a patent for a new stent that retains high radial strength but is more flexible and easier to insert into a patient’s coronary artery. The Crown™ stent is the product of our client DEKA’s collaboration with Cordis Corp., a Johnson & Johnson company, to improve the design of the Palmaz-Schatz® stent, the first intravascular stent proven to reduce blockage in arteries.

Juries. Patents. Success.

Comair Rotron, Inc. v Matsushita Electric Corp. of America

We obtained a $25 million judgment against industry giant Panasonic for willful infringement of our client Comair’s patents on fans for electronic equipment.

Exergen Corporation vs. Kaz, USA, Inc.

Sunstein lawyers won a $14.6M verdict for patent infringement following a two-week jury trial for our client Exergen, the people who pioneered the temporal artery thermometer.

Gates Formed-Fibre Products, Inc. v. Delaware Valley Corp.

By persuading a jury that the patents in suit were invalid, we successfully defended our client against accusations of infringement concerning a process for making fused-back automotive carpeting.

Winning at Post Grant Proceedings

Samsung Electronics Co., Ltd. v. Arendi  S.A.R.L.

Samsung attacked our client’s patent in the Patent Trial and Appeal Board (PTAB) on grounds of obviousness. We persuaded the PTAB that an element of the claims was not disclosed by the cited references and thus prevented the inter partes review from even being instituted.

Click here to learn more about Sunstein litigators.

 

Spotlight on Patents

A recent patent we obtained for our client Nexsan, of Santa Clara, CA,  U.S. Patent No. 9218406 covers a private cloud storage system in which security is maintained by storing the data on devices (sold under the Transporter brand) of  individual users.  Data is shared on a peer-to-peer basis.  A central  server governs access based on user privileges without storing any of  the shared data. This patent has issued in one of the fields in which recent court rulings have been propelling rapid evolution of the law.

In the News

  • Lisa Tittemore, SUNSTEIN Litigation Group Co-Chair, was a member of the committee that drafted extensive revisions to Local Rule 16.6, adopted by the U.S. District Court for D.MA effective June 1, 2018.  It is anticipated that the new rule will make the court a more appealing venue for patent litigation.

  • SUNSTEIN’s Federal Circuit Win in Exergen: Diagnostic Patents Survive Eligibility Challenge

    This is the first Federal Circuit decision upholding the patentability of a diagnostic patent since the Supreme Court struck down a diagnostic invention on patent eligibility grounds in Mayo v. Prometheus in 2012. More. . .  Law360 Article

  • SUNSTEIN has been named a Tier 1 firm in Boston for Litigation – Intellectual Property by U.S. News – Best Lawyers® “Best Law Firms” in 2018.

  • SUNSTEIN has been named a Recommended Firm by Chambers® in 2018.

     

  • Congratulations to our client Draper Laboratory for multiple awards for patents at the BPLA’s “Invented Here!” program. We are proud that Sunstein attorney George Jakobsche prosecuted the patents for Draper. More. . .

  • Sunstein successfully represented long-time client ’47 before USPTO’s TTAB preventing adversary’s registration of a 47 in a circle.  Read more here.

  • Congratulations to our client, the Broad Institute, on its Patent Trial and Appeal Board victory involving its patents for CRISPR gene-editing technology! We are pleased to have played a role in this victory. More. . .

  • Robert Asher wins Federal Circuit decision that issued a rare reversal of a PTAB patent invalidity decision and limited the discretion of the PTAB. More. . .

  • Bruce SunsteinKerry TimbersLisa TittemoreLawrence Green named to Best Lawyers in America©, 2018 list. More. . .

  • Lisa Tittemore, Kathy Williams, Ph.D.Dorothy Wu Chiang, Amy DeCloux, Ph.D., and Sharona Sternberg were named to the list of “Top Women Attorneys in Massachusetts” in Boston magazine.

Our Latest Thinking

  • Lawrence M. Green

    The Supreme Court says the Patent Act, which generally extends only to conduct occurring within the U.S., allows for enforcement of a U.S. patent against one specific overseas activity—the supplying of U.S.-made components to be assembled overseas in an infringing device. More...

  • Alexander J. Smolenski, Jr.

    A PTO memorandum, relying on a recent Federal Circuit decision, provides the life sciences industry with guidance on how to qualify method-of-treatment claims as patent-eligible subject matter. More...

  • Amy DeCloux, Ph.D., J.D.

    The recently signed Right to Try Act enables terminally ill patients to try experimental drugs that have completed Phase I testing but have not been approved by the FDA. It adds but little to existing “compassionate use” programs. More...

  • Steven A. Abreu

    A new study correlates companies’ pursuit of trademark registrations with the growth of their businesses. More...

  • Thomas C. Carey

    California’s new data privacy law requires many of the same protections that recently took effect in the EU. More...

  • Robert M. Asher

    PTAB Alert- The PTAB’s proposal to apply to IPRs the same claim construction standard used in federal litigation offers many benefits, but it may complicate validity challenges to indefinite claims. More...

Free Subscription

See more in Publications/News